P082/O24 Sclerostin Deficiency Affects RANKL-mediated Osteoclast Differentiation

doi 10.1136/annrheumdis-2018-ewrr2019.71
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway

2011English

A Novel Organosulfur Compound, Thiacremonone, Regulates RANKL-induced Osteoclast Differentiation

RSC Advances
ChemistryChemical Engineering
2017English

The 1,2,3-Triazole Derivative KP-A021 Suppresses Osteoclast Differentiation and Function by Inhibiting RANKL-mediated MEK-ERK Signaling Pathway

Experimental Biology and Medicine
MedicineBiochemistryGeneticsMolecular Biology
2015English

PTEN Regulates RANKL- And Osteopontin-Stimulated Signal Transduction During Osteoclast Differentiation and Cell Motility

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2002English

The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation

International Journal of Medical Sciences
Medicine
2017English

Osteoclast Differentiation Requires TAK1 and MKK6 for NFATc1 Induction and NF-κB Transactivation by RANKL

Cell Death and Differentiation
Cell BiologyMolecular Biology
2006English

Critical Roles of C-Jun Signaling in Regulation of NFAT Family and RANKL-regulated Osteoclast Differentiation

Journal of Clinical Investigation
Medicine
2004English

Blimp1-Mediated Repression of Negative Regulators Is Required for Osteoclast Differentiation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

RANKL, Osteopontin, and Osteoclast Homeostasis in a Hyperocclusion Mouse Model

European Journal of Oral Sciences
Dentistry
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy